These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9716420)

  • 1. A high-throughput fluorescence screen to monitor the specific binding of antagonists to RNA targets.
    Hamasaki K; Rando RR
    Anal Biochem; 1998 Aug; 261(2):183-90. PubMed ID: 9716420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.
    Wang Y; Hamasaki K; Rando RR
    Biochemistry; 1997 Jan; 36(4):768-79. PubMed ID: 9020774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence-based approach for detecting and characterizing antibiotic-induced conformational changes in ribosomal RNA: comparing aminoglycoside binding to prokaryotic and eukaryotic ribosomal RNA sequences.
    Kaul M; Barbieri CM; Pilch DS
    J Am Chem Soc; 2004 Mar; 126(11):3447-53. PubMed ID: 15025471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural origins of aminoglycoside specificity for prokaryotic ribosomes.
    Lynch SR; Puglisi JD
    J Mol Biol; 2001 Mar; 306(5):1037-58. PubMed ID: 11237617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Homo sapiens cytoplasmic ribosomal decoding A-site affinity screen evaluating aminoglycoside and analogue binding.
    Kythreoti G; Vourloumis D
    Anal Biochem; 2011 May; 412(1):102-7. PubMed ID: 21238425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific binding of aminoglycosides to a human rRNA construct based on a DNA polymorphism which causes aminoglycoside-induced deafness.
    Hamasaki K; Rando RR
    Biochemistry; 1997 Oct; 36(40):12323-8. PubMed ID: 9315872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.
    Yu L; Oost TK; Schkeryantz JM; Yang J; Janowick D; Fesik SW
    J Am Chem Soc; 2003 Apr; 125(15):4444-50. PubMed ID: 12683814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of translation initiation factor IF1 with the E. coli ribosomal A site.
    Dahlquist KD; Puglisi JD
    J Mol Biol; 2000 May; 299(1):1-15. PubMed ID: 10860719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycoside-induced reduction in nucleotide mobility at the ribosomal RNA A-site as a potentially key determinant of antibacterial activity.
    Kaul M; Barbieri CM; Pilch DS
    J Am Chem Soc; 2006 Feb; 128(4):1261-71. PubMed ID: 16433544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycoside microarrays to explore interactions of antibiotics with RNAs and proteins.
    Disney MD; Seeberger PH
    Chemistry; 2004 Jul; 10(13):3308-14. PubMed ID: 15224340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside resistance by ArmA-mediated ribosomal 16S methylation in human bacterial pathogens.
    Liou GF; Yoshizawa S; Courvalin P; Galimand M
    J Mol Biol; 2006 Jun; 359(2):358-64. PubMed ID: 16626740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA molecules that specifically and stoichiometrically bind aminoglycoside antibiotics with high affinities.
    Wang Y; Killian J; Hamasaki K; Rando RR
    Biochemistry; 1996 Sep; 35(38):12338-46. PubMed ID: 8823168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of a eukaryotic decoding region A-site RNA.
    Lynch SR; Puglisi JD
    J Mol Biol; 2001 Mar; 306(5):1023-35. PubMed ID: 11237616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal RNA constructs that specifically bind aminoglycoside antibiotics with high affinities.
    Hamasaki K; Killian J; Cho J; Rando RR
    Biochemistry; 1998 Jan; 37(2):656-63. PubMed ID: 9425088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.
    Foloppe N; Chen IJ; Davis B; Hold A; Morley D; Howes R
    Bioorg Med Chem; 2004 Mar; 12(5):935-47. PubMed ID: 14980606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docking of cationic antibiotics to negatively charged pockets in RNA folds.
    Hermann T; Westhof E
    J Med Chem; 1999 Apr; 42(7):1250-61. PubMed ID: 10197968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular recognition of aminoglycoside antibiotics by ribosomal RNA and resistance enzymes: an analysis of x-ray crystal structures.
    Vicens Q; Westhof E
    Biopolymers; 2003 Sep; 70(1):42-57. PubMed ID: 12925992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering the rRNA decoding site of eukaryotic cytosolic ribosomes in bacteria.
    Hobbie SN; Kalapala SK; Akshay S; Bruell C; Schmidt S; Dabow S; Vasella A; Sander P; Böttger EC
    Nucleic Acids Res; 2007; 35(18):6086-93. PubMed ID: 17766247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational constraint as a means for understanding RNA-aminoglycoside specificity.
    Blount KF; Zhao F; Hermann T; Tor Y
    J Am Chem Soc; 2005 Jul; 127(27):9818-29. PubMed ID: 15998086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.